Global Gastroenteritis Testing Market Size To Exceed USD 6.85 Billion By 2035 | CAGR Of 4.89%

Global Gastroenteritis Testing Market Size To Exceed USD 6.85 Billion By 2035

According to a research report published by Spherical Insights & Consulting, The Global Gastroenteritis Testing Market Size is Expected To Grow from USD 4.05 Billion in 2024 to USD 6.85 Billion by 2035, at a CAGR of 4.89% during the forecast period 2025-2035.

Browse 210 Market Data Tables And 45 Figures Spread Through 190 Pages and In-Depth TOC On the "Global Gastroenteritis Testing Market Size, Share, and COVID-19 Impact Analysis, By Disease Strains (Bacterial Strains, Viral Strains, and Parasitic Strains), By Product Type (Reagent Kits, Sequencing Kits, and Equipment), By Testing Methods (Immunoassay Testing, Conventional Testing, and Molecular Diagnostic Testing), By End-User (Hospitals, Clinics/Medical Centers, Research Institutes, and Diagnostic Laboratories), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035." Get Detailed Report Description Here:https://www.sphericalinsights.com/reports/gastroenteritis-testing-market

The Gastroenteritis Testing Market Size is an industry emphasizing the products and services for diagnosing the cause of gastroenteritis, which is a stomach and intestinal inflammation. Acute gastroenteritis caused by the norovirus, which is the most common cause of diarrhea and vomiting, affects 19-21 million people and causes around 900 deaths. There is a changing inclination towards syndromic diagnostics in clinical microbiology, for faster detection and more informed clinical decision-making in disease management. Technological advancements, including biosensors for early virus diagnosis associated with gastroenteritis, are providing market growth opportunities. The increasing prevalence of gastrointestinal disorders, along with the surging advancements in gastroenteritis testing for enhanced diagnostic accuracy, is driving the market growth. On the contrary, the limited adoption of advanced diagnostic platforms in low-resource settings, along with the lack of infrastructure & trained workforce, are hampering the gastroenteritis testing market.

The bacterial strains segment dominated the market with the largest revenue share of about 54%-60% in 2024 and is projected to grow at a substantial CAGR during the forecast period.

Based on the disease strains, The Gastroenteritis Testing Market Sizeis divided into bacterial strains, viral strains, and parasitic strains. Among these, the bacterial strains segment dominated the market with the largest revenue share of about 54%-60% in 2024 and is projected to grow at a substantial CAGR during the forecast period. Bacterial gastroenteritis is commonly called food poisoning, caused by various factors associated with dietary habits, with E. coli, Salmonella, and Campylobacter, being the most common disease-causing bacteria. An increasing need for specific treatment protocols in severe outbreaks, especially in the developing regions with inadequate sanitation, which results in propelling the market demand.

The reagent kits segment accounted for the largest revenue share of about 59.7% in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period.

Based on the product type, the gastroenteritis testing market is divided into reagent kits, sequencing kits, and equipment. Among these, the reagent kits segment accounted for the largest revenue share of about 59.7% in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. The segment includes rapid immunoassay strips to sophisticated multiplex PCR panels for identifying pathogens. Use of reagent kits for routine diagnostics, along with their ease of use, affordability, and accessibility, is propelling the segmental market growth.

The molecular diagnostic testing segment accounted for the largest market share of 41.8% in 2024 and is anticipated to grow at a significant CAGR during the forecast period.

Based on the testing methods, the gastroenteritis testing market is divided into immunoassay testing, conventional testing, and molecular diagnostic testing. Among these, the molecular diagnostic testing segment accounted for the largest market share of 41.8% in 2024 and is anticipated to grow at a significant CAGR during the forecast period. As compared to clinician-based testing, molecular diagnostics result in a 21% reduction in return healthcare visits. The preference for molecular diagnostic testing due to its superior accuracy, speed, and ability for simultaneous multiple pathogen detection is driving the market.

The hospitals segment accounted for the largest market share of about 42%-43% in 2024 and is anticipated to grow at a significant CAGR during the forecast period.

Based on the end-user, the gastroenteritis testing market is divided into hospitals, clinics/medical centers, research institutes, and diagnostic laboratories. Among these, the hospitals segment accounted for the largest market share of about 42%-43% in 2024 and is anticipated to grow at a significant CAGR during the forecast period. An isolation bay or side room in hospitals is used until the infection is eliminated or excluded. With an increasing number of patient admissions, the surging demand for immediate diagnosis and advanced testing capabilities is propelling the market demand in the hospitals segment.

North America is expected to hold the majority share of the global gastroenteritis testing market during the forecast period.

North America is expected to hold the majority share of about 40% in the global gastroenteritis testing market during the forecast period. The United States is capturing the largest revenue share of 78.5% in the North America gastroenteritis testing market, owing to increasing research on advanced gastroenteritis diagnostics. The region's well-established healthcare infrastructure and accessibility to clinical laboratories are driving the gastroenteritis testing market. Further, an increasing investment in the healthcare sector, with increasing innovation and application of advanced technologies, is contributing to driving the market.

Asia Pacific is anticipated to grow at the fastest pace of CAGR 23.5% in the global gastroenteritis testing market during the forecast period. India accounted for the largest revenue share of the gastroenteritis testing market in the Asia Pacific region, driven by government support for combating diarrheal diseases and growing awareness about infectious disease diagnostics. Increasing advancements in gastroenterological diagnostics with innovative AI-assisted technology by the health-tech startups are propelling market growth. Further, increasing collaborations with research organizations is promoting market growth.

Major vendors in the global gastroenteritis testing market are BD, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Sanofi, Pfizer Inc., GSK plc, Novartis AG, AstraZeneca, Johnson & Johnson Private Limited, Sun Pharmaceutical Industries Ltd., Merck & Co., Inc., Lilly, Amgen Inc., Hainan Poly Co. Ltd, WOCKHARDT, and Others.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Key Market Development 

• In October 2025, Hologic, Inc. announced that the U.S. Food and Drug Administration (FDA) had granted 510(k) clearance for the Panther Fusion Gastrointestinal (GI) Bacterial and Expanded Bacterial Assays.   
• In January 2025, RNT Health Insights, a Chandigarh-based health-tech startup advances gastroenterological diagnostics with its innovative AI-assisted technology, aimed at improving early detection and survival outcomes for esophageal cancer patients.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Gastroenteritis Testing market based on the below-mentioned segments:

Global Gastroenteritis Testing Market, By Disease Strains   

• Bacterial Strains
• Viral Strains
• Parasitic Strains

Global Gastroenteritis Testing Market, By Product Type

• Reagent Kits
• Sequencing Kits
• Equipment

Global Gastroenteritis Testing Market, By Testing Methods

• Immunoassay Testing
• Conventional Testing
• Molecular Diagnostic Testing

Global Gastroenteritis Testing Market, By End-User

• Hospitals
• Clinics/Medical Centers
• Research Institutes
• Diagnostic Laboratories

 Global Gastroenteritis Testing Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa

About the Spherical Insights & Consulting

Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.

Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements. 

CONTACT US:

For More Information on Your Target Market, Please Contact Us Below:    

Phone: +1 303 800 4326 (the U.S.)

Phone: +91 90289 24100 (APAC)

Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com

Contact Us: https://www.sphericalinsights.com/contact-us

Follow Us: LinkedIn | Facebook | Twitter